AU4134297A - 2,4-disubstituted pyrimidine derivatives, process for producing the same, and medicinal compositions containing the same - Google Patents

2,4-disubstituted pyrimidine derivatives, process for producing the same, and medicinal compositions containing the same

Info

Publication number
AU4134297A
AU4134297A AU41342/97A AU4134297A AU4134297A AU 4134297 A AU4134297 A AU 4134297A AU 41342/97 A AU41342/97 A AU 41342/97A AU 4134297 A AU4134297 A AU 4134297A AU 4134297 A AU4134297 A AU 4134297A
Authority
AU
Australia
Prior art keywords
same
producing
compositions containing
pyrimidine derivatives
medicinal compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41342/97A
Inventor
Kiyoshi Furukawa
Katsunori Kondo
Teruya Murata
Makoto Oka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dainippon Pharmaceutical Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Publication of AU4134297A publication Critical patent/AU4134297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU41342/97A 1996-09-04 1997-09-03 2,4-disubstituted pyrimidine derivatives, process for producing the same, and medicinal compositions containing the same Abandoned AU4134297A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25542096 1996-09-04
JP8-255420 1996-09-04
PCT/JP1997/003079 WO1998009960A1 (en) 1996-09-04 1997-09-03 2,4-disubstituted pyrimidine derivatives, process for producing the same, and medicinal compositions containing the same

Publications (1)

Publication Number Publication Date
AU4134297A true AU4134297A (en) 1998-03-26

Family

ID=17278521

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41342/97A Abandoned AU4134297A (en) 1996-09-04 1997-09-03 2,4-disubstituted pyrimidine derivatives, process for producing the same, and medicinal compositions containing the same

Country Status (5)

Country Link
AR (1) AR009523A1 (en)
AU (1) AU4134297A (en)
ID (1) ID17076A (en)
WO (1) WO1998009960A1 (en)
ZA (1) ZA977427B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432947B1 (en) 1997-02-19 2002-08-13 Berlex Laboratories, Inc. N-heterocyclic derivatives as NOS inhibitors
JP2002241369A (en) * 1998-05-18 2002-08-28 Dainippon Pharmaceut Co Ltd 4-pyrimidinylaminoacetamide derivative and pharmaceutical composition containing the same
AU2004200A (en) * 1999-01-14 2000-08-01 Meiji Seika Kaisha Ltd. Poly(adp-ribose) polymerase inhibitors consisting of pyrimidine derivatives
CN1170823C (en) 1999-11-17 2004-10-13 大日本制药株式会社 [5-chloro-6-phenyl-2-(4-trifluoromethylphenyl)-4-pyrimidinyl amino] acetamide derivatives, process for producing the same, medicinal compositions the same and intermediate of these compounds
US6525051B2 (en) 2000-03-27 2003-02-25 Schering Aktiengesellschaft N-heterocyclic derivatives as NOS inhibitors
EP2198867A1 (en) 2001-12-07 2010-06-23 Vertex Pharmaceuticals, Inc. Pyrimidine-based compounds useful as GSK-3 inhibitors
US6982259B2 (en) 2002-04-30 2006-01-03 Schering Aktiengesellschaft N-heterocyclic derivatives as NOS inhibitors
CA2541989C (en) * 2003-10-24 2013-10-01 Exelixis, Inc. P70s6 kinase modulators and method of use
EP1939181A1 (en) * 2006-12-27 2008-07-02 sanofi-aventis Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO synthase
WO2008116139A2 (en) * 2007-03-22 2008-09-25 Vertex Pharmaceuticals Incorporated N-heterocyclic compounds useful as inhibitors of janus kinases
GB0808664D0 (en) * 2008-05-13 2008-06-18 Syngenta Ltd Chemical compounds
US8691866B2 (en) 2008-12-10 2014-04-08 The General Hospital Corporation HIF inhibitors and use thereof
JP2012529535A (en) 2009-06-12 2012-11-22 ブリストル−マイヤーズ スクイブ カンパニー Nicotinamide compounds useful as kinase modulators
EP3887364A1 (en) * 2018-11-30 2021-10-06 Celularity Inc. Aromatic compounds for use in activating hematopoietic stem and progenitor cells
CN115551840A (en) * 2020-05-19 2022-12-30 优迈特株式会社 Fluorine-containing pyrimidine compound and fluorine-containing pyrimidinone compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0710874A (en) * 1993-04-28 1995-01-13 Dainippon Pharmaceut Co Ltd 3-(1,2,4-oxadiazolyl)-5,6,7,8-tetrahydro-1,6-naphtyridine derivative
JPH07165721A (en) * 1993-12-15 1995-06-27 Sumitomo Chem Co Ltd Radeioactive isoquinolinecarboxamide derivative

Also Published As

Publication number Publication date
AR009523A1 (en) 2000-04-26
ID17076A (en) 1997-12-04
ZA977427B (en) 1998-03-02
WO1998009960A1 (en) 1998-03-12

Similar Documents

Publication Publication Date Title
HK1028769A1 (en) 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
HUP9802565A3 (en) N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same
HUS1400001I1 (en) Quinazoline derivatives, producing them and pharmaceutical compositions containing the compounds
HUP9904521A3 (en) Piperazine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0003309A3 (en) Imidazolyl-cyclic acetals, process for producing them and pharmaceutical compositions containing the same
HUP0004334A2 (en) Substituted 1,2,3,4-tetrahydronaphthalene derivatives, process for producing them and pharmaceutical compositions containing them
AU8627898A (en) Pyrimidin-2,4,6-trion derivatives, method for producing the same and medicinal products containing these compounds
AU3031797A (en) New substituted 2,4-thiazolidinedione derivatives, processes for producing them and pharmaceutical compositions containing them
HUP9901739A3 (en) Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them
HUP9702042A3 (en) Use of 1,1,2-triphenil but-1-ene derivatives for the production of medicaments against atherosclerosis
AU4134297A (en) 2,4-disubstituted pyrimidine derivatives, process for producing the same, and medicinal compositions containing the same
HUP9901473A3 (en) 2,3-benzodiazepine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0102400A3 (en) Substituted octalydropyrido[1,2a]pyrazin derivatives and pharmaceutical compositions containing the same
HUP9701660A3 (en) 10,13,15-trioxatricyclo[9.2.1.1.9.6]pentadekanon derivatives, process for producing them, and pharmaceutical compositions containing them
HUP9602868A3 (en) 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
AU2397997A (en) Process for making 4,6-dihydroxypyrimidine
HUT74615A (en) 2,3-cyclic-condensed-1,4-dihydro-pyridine derivatives, process for producing them and pharmaceutical compositions containing the same
HU9602763D0 (en) Novel isoxazole derivatives, process for producing them and pharmaceutical compositions containing the same
AU2912097A (en) Novel piperazine or homopiperazine derivatives, pharmaceutical compositions containing the same and process for their preparation
AU6124599A (en) 1,5-benzodiazepine compounds, process for producing the same, and medicine
HU9900263D0 (en) 11-acetyl-12,13-dioxabicyclo[8.2.1.]tridecenon derivatives, process for producing them and pharmaceutical compositions containing them
AU4845196A (en) 2-sulfinylnicotinamide derivatives, intermediate thereof, process for producing 2-sulfinylnicotinamide derivatives, and medicinal composition containing the same as active ingredient
HUP0004177A3 (en) 4,5-diaryloxazole derivatives, pharmaceutical compositions containing them and process for producing them
AU2742397A (en) Processes for producing 1,6-hexanedials and derivatives
AU9198698A (en) Process for the preparation of substituted 5,6-dihydro-2h-pyran-2-ones